0001209191-18-007614.txt : 20180205 0001209191-18-007614.hdr.sgml : 20180205 20180205173956 ACCESSION NUMBER: 0001209191-18-007614 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180201 FILED AS OF DATE: 20180205 DATE AS OF CHANGE: 20180205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silva Paul M CENTRAL INDEX KEY: 0001446372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 18575416 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-01 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001446372 Silva Paul M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 SVP & Corp Controller Common Stock 2018-02-01 4 M 0 8594 96.87 A 25228 D Common Stock 2018-02-01 4 S 0 8594 174.11 D 16634 D Common Stock 2018-02-02 4 M 0 1289 91.05 A 17923 D Common Stock 2018-02-02 4 S 0 1289 169.42 D 16634 D Common Stock 169 I 401(k) Stock Option (Right to Buy) 96.87 2018-02-01 4 M 0 8594 0.00 D 2024-07-14 Common Stock 8594 1719 D Stock Option (Right to Buy) 91.05 2018-02-02 4 M 0 1289 0.00 D 2026-02-01 Common Stock 1289 10313 D Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1. The option vests in 16 quarterly installments from 7/15/2014. The option vests in 16 quarterly installments from 2/2/2016. /s/ Omar White, Attorney-in-Fact 2018-02-05